BioCentury | Jul 25, 2020
Product Development

NIH, HHS fast-tracking point-of-care, pooled tech as way out of testing crunch

...OTCQX:RHHBY) and Hologic Inc. (NASDAQ:HOLX) are in limited supply, and point-of-care molecular tests from the Cepheid Inc....
BioCentury | May 20, 2020
Product Development

Roche, Abbott say sample collection differences hampered COVID-19 sensitivity in independent studies

...missed a large fraction of positive samples caught by another rapid test from the Cepheid...
...lower LoD indicates a more sensitive test; Abbott reported an LoD of 125 copies/mL, while Cepheid’s...
BioCentury | May 14, 2020
Product Development

New scrutiny prompts withdrawal, re-evaluation of two rapid COVID-19 tests

...missed a large fraction of positive cases detected by the Xpert Xpress test from the Cepheid...
...Detection” ). Specifically, ID NOW COVID-19 missed a third of the samples deemed positive by Cepheid’s...
...Friday, May 15 to reflect Abbott’s news. Karen Tkach Tuzman, Associate Editor Becton Dickinson and Co. BioMedomics Inc. Abbott Laboratories Cepheid Inc. cov19count antibody...
BioCentury | May 12, 2020
Product Development

White House highlights new COVID-19 antigen test amidst focus on point-of-care technologies

...House’s presentation also called out rapid point-of-care nucleic acid tests from Abbott Laboratories (NYSE:ABT) and Cepheid Inc....
BioCentury | May 7, 2020
Regulation

CRISPR comes of age years ahead of schedule with first diagnostic authorization

...is sufficient (see “Pushing the Limits of Detection” ). Although Sherlock announced a collaboration with Cepheid Inc....
BioCentury | Apr 15, 2020
Politics, Policy & Law

Medicare raises payments to increase high-throughput COVID-19 testing

...Abbott Laboratories (NYSE:ABT); Panther Fusion System from Hologic Inc. (NASDAQ:HOLX); GeneXpert Infinity System from the Cepheid...
BioCentury | Mar 28, 2020
Product Development

COVID-19 crisis spurs innovation in rapid diagnostic technologies

...first rapid PCR test authorized by FDA was the Xpert Xpress SARS-CoV-2 test from the Cepheid...
BioCentury | Mar 28, 2020
Product Development

COVID-19 diagnostic tech tableau

...on thermocycling time and can be performed at the bedside. In the last week, the Cepheid Inc....
BioCentury | Mar 22, 2020
Regulation

FDA authorizes first COVID-19 point-of-care diagnostic

...FDA granted Emergency Use Authorization to Cepheid’s Xpert Xpress SARS-CoV-2 test, the first point-of-care diagnostic for...
...run in centralized or references labs. The new rapid RT-PCR test can be performed anywhere Cepheid’s...
...systems have been installed worldwide, almost 5,000 of which are in the U.S. Last month, Cepheid...
BioCentury | Feb 29, 2020
Product Development

CRISPR-based diagnostics are poised to make an early debut amid COVID-19 outbreak

...Sherlock announced a collaboration with Cepheid to run SHERLOCK tests for infectious diseases on the Cepheid’s...
...of concept for the research collaboration. The tests developed with Cepheid can be used anywhere Cepheid’s...
...may be a centralized lab setting or hospitals. Over 23,000 GeneXpert systems have been installed. Cepheid...
Items per page:
1 - 10 of 293
BioCentury | Jul 25, 2020
Product Development

NIH, HHS fast-tracking point-of-care, pooled tech as way out of testing crunch

...OTCQX:RHHBY) and Hologic Inc. (NASDAQ:HOLX) are in limited supply, and point-of-care molecular tests from the Cepheid Inc....
BioCentury | May 20, 2020
Product Development

Roche, Abbott say sample collection differences hampered COVID-19 sensitivity in independent studies

...missed a large fraction of positive samples caught by another rapid test from the Cepheid...
...lower LoD indicates a more sensitive test; Abbott reported an LoD of 125 copies/mL, while Cepheid’s...
BioCentury | May 14, 2020
Product Development

New scrutiny prompts withdrawal, re-evaluation of two rapid COVID-19 tests

...missed a large fraction of positive cases detected by the Xpert Xpress test from the Cepheid...
...Detection” ). Specifically, ID NOW COVID-19 missed a third of the samples deemed positive by Cepheid’s...
...Friday, May 15 to reflect Abbott’s news. Karen Tkach Tuzman, Associate Editor Becton Dickinson and Co. BioMedomics Inc. Abbott Laboratories Cepheid Inc. cov19count antibody...
BioCentury | May 12, 2020
Product Development

White House highlights new COVID-19 antigen test amidst focus on point-of-care technologies

...House’s presentation also called out rapid point-of-care nucleic acid tests from Abbott Laboratories (NYSE:ABT) and Cepheid Inc....
BioCentury | May 7, 2020
Regulation

CRISPR comes of age years ahead of schedule with first diagnostic authorization

...is sufficient (see “Pushing the Limits of Detection” ). Although Sherlock announced a collaboration with Cepheid Inc....
BioCentury | Apr 15, 2020
Politics, Policy & Law

Medicare raises payments to increase high-throughput COVID-19 testing

...Abbott Laboratories (NYSE:ABT); Panther Fusion System from Hologic Inc. (NASDAQ:HOLX); GeneXpert Infinity System from the Cepheid...
BioCentury | Mar 28, 2020
Product Development

COVID-19 crisis spurs innovation in rapid diagnostic technologies

...first rapid PCR test authorized by FDA was the Xpert Xpress SARS-CoV-2 test from the Cepheid...
BioCentury | Mar 28, 2020
Product Development

COVID-19 diagnostic tech tableau

...on thermocycling time and can be performed at the bedside. In the last week, the Cepheid Inc....
BioCentury | Mar 22, 2020
Regulation

FDA authorizes first COVID-19 point-of-care diagnostic

...FDA granted Emergency Use Authorization to Cepheid’s Xpert Xpress SARS-CoV-2 test, the first point-of-care diagnostic for...
...run in centralized or references labs. The new rapid RT-PCR test can be performed anywhere Cepheid’s...
...systems have been installed worldwide, almost 5,000 of which are in the U.S. Last month, Cepheid...
BioCentury | Feb 29, 2020
Product Development

CRISPR-based diagnostics are poised to make an early debut amid COVID-19 outbreak

...Sherlock announced a collaboration with Cepheid to run SHERLOCK tests for infectious diseases on the Cepheid’s...
...of concept for the research collaboration. The tests developed with Cepheid can be used anywhere Cepheid’s...
...may be a centralized lab setting or hospitals. Over 23,000 GeneXpert systems have been installed. Cepheid...
Items per page:
1 - 10 of 293